CD206+,RP-182

Hualin Cao1,2, Xiaoye Chen2, Ruyue Jin3

  • 1Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Frontiers in pharmacology
|February 16, 2026
PubMed
概括

类RP-182向CD206+巨细胞,以减少阻塞性病中的纤维化. 这种方法抑制M2极化和巨细胞转移到肌纤维细胞,为慢性病提供了新的治疗策略.